Circulation, Vol 71, 363-369, Copyright © 1985 by American Heart Association
H Hashimoto, DR Abendschein, AW Strauss and BE Sobel
To determine whether myocardial infarction could be detected early after
onset by analysis of subforms of the MM isoenzyme (isoforms) of creatine
kinase (MM CK) in plasma, we subjected eight conscious dogs to coronary
occlusion and quantified isoforms in serial plasma samples by
chromatofocusing. The fractions of MMA (isoelectric point [pI] = 7.91), MMB
(pI = 7.74), and MMC (pI = 7.51) in plasma samples before coronary
occlusion averaged 11.4 +/- 4.8% (SD), 22.3 +/- 5.5%, and 66.3 +/- 9.6% of
total MM CK activity. The fraction of MMA, the isoform of MM CK found in
myocardium, increased significantly in plasma 1 hr after coronary
occlusion, reached a maximum of 49.7 +/- 8.0% in 4.1 +/- 1.3 hr, and
returned to baseline in 12.0 +/- 2.3 hr. The fraction of plasma MM CK
activity attributable to MMC, an isoform formed slowly in plasma from MMA
via MMB as an intermediate, decreased significantly within 1 hr, reached a
minimum of 14.0 +/- 4.1% in 4.8 +/- 1.1 hr, and returned to baseline in
13.0 +/- 2.9 hr after coronary occlusion. Total CK activity did not
increase significantly until later, i.e., 5 hr after occlusion, and peaked
at 1371 +/- 530 IU/liter in 10.9 +/- 1.9 hr. Within the first 4 hr after
coronary occlusion, MMA consistently comprised more than 20% of plasma MM
CK activity despite insignificant increase of total CK. Changes in isoform
proportions were consistent and independent of peak total CK activity and
of cumulative CK release over a 10-fold range. Thus initial CK release
indicative of infarction is detectable within 1 hr after the onset of
ischemia by quantification of plasma MM CK isoforms.
ARTICLES
Early detection of myocardial infarction in conscious dogs by analysis of plasma MM creatine kinase isoforms
This article has been cited by other articles:
![]() |
K. W. Baran, M. Nguyen, G. R. McKendall, C. T. Lambrew, G. Dykstra, S. T. Palmeri, R. J. Gibbons, S. Borzak, B. E. Sobel, S. G. Gourlay, et al. Double-Blind, Randomized Trial of an Anti-CD18 Antibody in Conjunction With Recombinant Tissue Plasminogen Activator for Acute Myocardial Infarction: Limitation of Myocardial Infarction Following Thrombolysis in Acute Myocardial Infarction (LIMIT AMI) Study Circulation, December 4, 2001; 104(23): 2778 - 2783. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. LEE and L. GOLDMAN Serum Enzyme Assays in the Diagnosis of Acute Myocardial InfarctionRecommendations Based on a Quantitative Analysis Ann Intern Med, August 1, 1986; 105(2): 221 - 233. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |